Skip to main content

Table 1 Goals of therapy, monitors and main outcomes

From: Clinical review: What are the best hemodynamic targets for noncardiac surgical patients?

Variable Monitor Reported clinical effects [references]
Dynamic indices of fluid responsiveness   
   Corrected flow time TED Decrease LOS or complications [22, 24, 28], increase LOS [61, 62]
   Stroke volume TED, Vigileo FloTracsystem™, LiDCOrapid™ Decrease LOS or complications [2328]
   Pulse pressure variation Multiparametric monitor, LiDCOrapid™ Decrease LOS and complications [30]
   Plethysmography variability index Plethysmography None [31]
   Stroke volume variation Vigileo/FloTracsystem™, LiDCOrapid™ Decrease LOS and complications [32]
   Systolic pressure variation PiCCOplus™ None [33]
Flow indices   
   Oxygen delivery PAC, LiDCOplus™, Vigileo/FloTracsystem™ Decrease mortality [3538], decrease complications [3538, 64, 65, 68], none [66]
   Cardiac index PAC Decrease complications [39], none [4043]
Indices of adequacy of perfusion   
   Venous oxygen saturation PAC None [52]
   Oxygen extraction ratio Blood gas Decrease complications [53]
  1. LiDCOplus™, LiDCO system (LiDCO Ltd, London, UK); LiDCOrapid™, LiDCO system ((LiDCO); LOS, length of stay; PAC, pulmonary artery catheter; PiCCOplus™, PiCCO system (Pulsion Medical Systems AG, Munich, Germany); TED, transesophageal Doppler; Vigileo, Vigileo system (Edwards, Irvine, CA, USA).